D.E. Shaw & Co’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.99M | Sell |
252,981
-66,723
| -21% | -$2.11M | 0.01% | 1181 |
|
|
2025
Q1 | $10.6M | Sell |
319,704
-160,901
| -33% | -$5.34M | 0.01% | 956 |
|
|
2024
Q4 | $16.5M | Buy |
480,605
+124,656
| +35% | +$4.29M | 0.01% | 755 |
|
|
2024
Q3 | $14.2M | Buy |
355,949
+45,945
| +15% | +$1.84M | 0.01% | 804 |
|
|
2024
Q2 | $9.35M | Buy |
310,004
+30,569
| +11% | +$922K | 0.01% | 937 |
|
|
2024
Q1 | $9.38M | Sell |
279,435
-2,321
| -0.8% | -$77.9K | 0.01% | 940 |
|
|
2023
Q4 | $9.1M | Buy |
281,756
+13,943
| +5% | +$450K | 0.01% | 900 |
|
|
2023
Q3 | $8.78M | Buy |
267,813
+27,352
| +11% | +$896K | 0.01% | 891 |
|
|
2023
Q2 | $8.46M | Buy |
240,461
+45,975
| +24% | +$1.62M | 0.01% | 978 |
|
|
2023
Q1 | $6.35M | Sell |
194,486
-29,485
| -13% | -$963K | 0.01% | 1205 |
|
|
2022
Q4 | $12.3M | Buy |
223,971
+177,772
| +385% | +$9.8M | 0.01% | 847 |
|
|
2022
Q3 | $2.05M | Buy |
46,199
+9,423
| +26% | +$417K | ﹤0.01% | 2097 |
|
|
2022
Q2 | $1.79M | Buy |
36,776
+8,317
| +29% | +$406K | ﹤0.01% | 2327 |
|
|
2022
Q1 | $1.39M | Buy |
+28,459
| New | +$1.39M | ﹤0.01% | 2670 |
|
|
2021
Q3 | – | Sell |
-44,765
| Closed | -$1.26M | – | 3715 |
|
|
2021
Q2 | $1.26M | Buy |
+44,765
| New | +$1.26M | ﹤0.01% | 2365 |
|